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Résumé en
anglais
Evans syndrome (ES) is defined by the combination of autoimmune hemolytic anemia
and immune thrombocytopenia. Clinical presentation includes manifestations of
immune dysregulation, found in primary immune deficiencies, autoimmune
lymphoproliferative syndrome with FAS (ALPS-FAS), Cytotoxic T Lymphocyte
Antigen-4 (CTLA-4) and Lipopolysaccharide-Responsive vesicle trafficking Beige-like
and Anchor protein (LRBA) defects. We report the clinical history and genetic results
of 18 children with ES after excluding ALPS-FAS. Thirteen had organomegaly, five
lymphocytic infiltration of non-lymphoid organs, nine hypogammaglobulinemia and
fifteen anomalies in lymphocyte phenotyping. Seven patients had genetic defects:
three CTLA4 mutations (c.151C>T; c.109+1092_568-512del; c.110-2A>G) identified by
Sanger sequencing and four revealed by Next Generation Sequencing: LRBA
(c.2450+1C>T), STAT3 gain-of-function (c.2147C>T; c.2144C>T) and KRAS
(c.37G>T). No feature emerged to distinguish patients with or without genetic
diagnosis. Our data on pediatric-onset ES should prompt physicians to perform
extensive screening for mutations in the growing pool of genes involved in primary
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